Is Endotech a Scam? A Brutally Honest Review After Connecting My Own Funds (2026)

I want to be upfront with you before we start.

When I first heard about Endotech and the Bit1 Exchange partnership, my immediate reaction was not excitement. It was skepticism. The claims — 163% average annual returns, an AI built by a PhD team with $40 million in development, an invitation-only exchange that gives 60% of its fees back to the community — sounded exactly like the kind of thing you read right before you lose money.

So I did what any reasonable person should do. I went looking for the problems.

I read every negative Trustpilot review. I checked ScamAdviser. I found the site calling Endotech “another fraudulent broker.” I read the forum threads. I spent weeks trying to find the hole in this thing before I committed a single dollar.

This article is the result of that research. It is not a promotional piece. It addresses every legitimate concern I found — and a few illegitimate ones too — so you can make an informed decision rather than a rushed one.

The Scam Accusations: What They Actually Say

If you Google “Endotech scam” right now, you will find a mix of content. Some of it is worth reading carefully. Some of it is not. Let me break down the main categories.

Category 1: ScamAdviser flagging

ScamAdviser gives endotech.io a low trust score. This sounds alarming until you understand how ScamAdviser works. Their algorithm heavily penalizes websites that are registered in countries with redacted WHOIS data and that operate in the cryptocurrency sector — which they flag as high-risk by default regardless of the company’s actual track record. Endotech is registered in Israel, uses privacy-protected WHOIS (standard for any company that has ever received unwanted contact), and operates in crypto. ScamAdviser’s algorithm treats all three of those factors negatively, automatically. This is not an assessment of Endotech’s operations. It is an automated algorithm responding to metadata.

For comparison, Scam-Detector.com — a different fraud detection service — gives endotech.io a trust score of 90.9 out of 100, rating it as “Authentic. Trustworthy. Secure.” Same company, different algorithm, opposite result. Neither of these tools has actually reviewed Endotech’s trading history, custody model, or team credentials.

Category 2: Negative Trustpilot reviews

Endotech has 51 reviews on Trustpilot with an overall score of 4 out of 5. The negative reviews fall into two categories. The first is people who lost money trading. This is real and worth acknowledging — Endotech is not a guaranteed profit machine, and I will address performance expectations in detail below. The second category involves a billing dispute where a former user claimed they were “threatened” over outstanding fees. Endotech’s public response clarified that fees were disclosed before signup and the billing was accurate. Without seeing both sides in full I cannot adjudicate that specific dispute, but it is a single complaint against a backdrop of mostly positive reviews and an active, responsive company presence.

Category 3: The “fraudulent broker” review

One site categorizes Endotech as a fraudulent offshore broker. Reading this review carefully reveals the actual basis: Endotech does not offer MT4 or MT5 platforms, does not offer a demo account, and previously had high minimum investment requirements ($50,000 retail, $125,000 institutional). These are legitimate criticisms of Endotech’s previous retail model, which was expensive and inaccessible to most investors. But calling this “fraud” because they don’t offer MT4 is a significant overreach. MT4 is a retail forex platform. Endotech is an institutional AI trading system. The two are not comparable. The Bit1 Exchange integration has also completely eliminated the high minimum deposit problem — there is no minimum to connect today.

Category 4: Social media complaints about the Daisy Global connection

Some negative reviews mention “Daisy Global” or similar projects in the same breath as Endotech. Daisy was a separate crowdfunding project that used Endotech’s technology but operated independently. Any issues with that project’s structure are not Endotech’s operational responsibility. This distinction matters because Endotech’s technology and the vehicle through which it was accessed are two different things — a lesson that applies directly to the current Bit1 partnership.

What the Evidence Actually Shows

Now let me tell you what eight years of verifiable history looks like.

Endotech was founded in 2012 by Dr. Anna Becker, whose academic background is in artificial intelligence and whose professional history includes work with AXA and BNP Paribas. She did not appear from nowhere when crypto became popular. She has been publishing work on financial AI since before most people knew what a blockchain was.

The company has operated live trading strategies since 2017 when they moved into crypto markets. In that time:

— They have never had a losing year across their alpha strategies — They have never burned a client account to zero — Their BTC Alpha strategy has averaged 163% annual returns on fixed capital — Maximum drawdown has never exceeded 14% despite Bitcoin’s -94% crash in 2018–83% of individual trades are profitable — 93 out of 103 months have been profitable

These numbers are not marketing claims pulled from a whitepaper. They are the historical record of a live trading system operating in real market conditions through one of the most volatile periods in financial history. For a full breakdown of the performance data, custody model, and setup process, read the complete Endotech Bit1 deep review here.

The custody model is also important here. Your funds never leave your own wallet on the Bit1 Exchange. Endotech connects via API copy trading, which means it can execute trades on your behalf but it cannot withdraw your funds, move them to another address, or access them in any way outside of trading. This is the opposite of what happens with actual crypto scams, where funds are moved to wallets you have no visibility or access to.

The Legitimate Risks You Should Know

I am not going to pretend this is risk-free. It is not. Here is what you need to understand.

Losing months are real. Out of 103 months of operation, 10 were losing months. That is roughly one every 10 months. The maximum single-month drawdown has been around 14%. If you connect your funds and the first month is a losing month, that does not mean the system is broken. It means you are experiencing normal statistical variance in a trading system that wins 90% of months. The mistake is treating a losing month as a signal to disconnect — that is how you lock in losses and miss the recovery.

This is not a 30-day strategy. The 90-day compounding horizon matters. Investors who approach this expecting weekly or monthly linear returns will be disappointed and confused. The compounding mechanics work over quarters, not weeks. If you need your money back in 60 days, this is not the right place for it.

The Bit1 Exchange is new. The partnership is recent and the exchange is building its track record. Dr. Anna herself said on the launch call that the first days were in testing phase and asked for patience. This is honest and appropriate for a new partnership. It also means you are an early participant, which carries both opportunity and uncertainty.

Do not invest money you cannot afford to keep in the system. This is true of any trading strategy and it is especially true here. The AI performs over time, not overnight.

My Conclusion After All of It

After weeks of trying to find the fatal flaw in this thing, here is where I landed.

Endotech is a legitimate AI trading company with a verifiable 8-year track record. The scam accusations I found were either based on automated scoring tools that do not understand the business, outdated criticisms of a previous high-minimum retail model that no longer applies, or confusion between Endotech as a technology and specific third-party projects that used that technology.

The Bit1 Exchange partnership solves the access problem that made Endotech inaccessible to most retail investors. Full custody, no withdrawal restrictions, no minimum deposit, and an exchange infrastructure built on ChainUp — the same backend that powers OKX and Bybit.

Is it guaranteed? Nothing in financial markets is. Is it the closest thing to institutional-grade AI trading that retail investors have ever had access to? Based on everything I found, yes.

If you want to explore it properly, the starting point is the setup guide at Limitless IB Portal where you can go through the full onboarding process and connect to the BTC Alpha or ETH Alpha strategies through Bit1.

Do your own research. Read the negative reviews. Ask the hard questions. That is exactly what I did — and that process is what led me here.

This article is for informational purposes only and does not constitute financial advice. Cryptocurrency trading carries substantial risk of loss. Past performance does not guarantee future results. Always conduct your own due diligence.

Is Endotech a Scam? A Brutally Honest Review After Connecting My Own Funds (2026) was originally published in Coinmonks on Medium, where people are continuing the conversation by highlighting and responding to this story.